Rentschler Biotechnologie, a Laupheim, Germany-based contract development and manufacturing organization for biopharmaceuticals, has opened a new single-use bioreactor at the company’s site in Laupheim with a capacity of 2,000 liters. This expansion follows an expansion of cGMP manufacturing capacity recently, which put into operation a twin system of two 3,000-liter stainless-steel bioreactors.

In combination with its first 2,000-liter single-use bioreactor put into operation in 2015, Rentschler now has two 1,000-liter and two 2,000-liter single-use manufacturing systems. This enables the manufacturing of recombinant proteins in single-use bioreactors for late-stage clinical development and market supply of biopharmaceuticals.

Over the course of the continuous capacity expansion and investments at the Laupheim site, Rentschler said it will add staff, including process engineers and laboratory technicians in bioprocess development and manufacturing as well as GMP experts.

Source: Rentschler Biotechnologie